Unknown NA INTERVENTIONAL 1-arm NCT04836676

Clinical Validation of C-REX Device for Adaptive Anastomoses (C-REX)

Clinical Validation of C-REX Device for Adaptive Anastomoses: A Multicentre Non-Randomised Controlled Study for Post-Market Clinical Follow-up

Sponsor: Capio Sankt Görans Hospital

Conditions Cancer Colonic

Interventions C-REX Device

Updated 4 times since 2021 Last updated: Apr 8, 2021 Started: Apr 30, 2021 Primary completion: Apr 30, 2023 Completion: Apr 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Cancer Colonic, this trial is ongoing. The trial is conducted by Capio Sankt Görans Hospital and has accumulated 4 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
May 2023 — Jul 2024 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
May 2021 — May 2023 [monthly]

Not Yet Recruiting NA

First recorded

Apr 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Capio Sankt Görans Hospital
Carponovum AB
Danderyd Hospital
Ersta Diakoni
Karolinska University Hospital
Stockholm South General Hospital

Data source: Carponovum AB

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Danderyd, Sweden
• Stockholm, Sweden